NTC at CPhI - Frankfurt 2019 - Stand 91B71

  • Nov 05, 2019

CPhI Worldwide, 5-7 November 2019.
See you in Frankfurt.

Lertal® significantly favors good functioning of the immune system

  • Sept 03, 2019

Lertal® significantly favors good functioning of the immune system the immune system’s activity and improves the management of rhinoconjunctivitis in children.

NTC ACQUIRES FROM NMTECH UK TiAb AND SIAB BASED TECHNOLOGY

  • June 12, 2019

Milan, Italy, June 12, 2019 – NTC focuses on strengthening its gynecology, dermatology and ophthalmology portfolio and pipeline.

NEW LIFE FOR PATIENTS SUFFERING FROM BLEPHARITIS: a controlled clinical study was presented on Blefastop, an ocular and periocular innovative therapeutic solution as adjuvant in blepharitis.

  • June 5, 2019

Milan, June 5, 2019 – Recently, a controlled clinical study was presented on Blefastop, an ocular and periocular innovative therapeutic solution as adjuvant in blepharitis.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. READ MORE